Ultralife Corporation (NASDAQ: ULBI) has reported its Q2 financial results which reveal both positive and negative aspects:
Key Financial Highlights:
Revenue: Q2 2025 revenues increased to $48.6 million, up 13.0% from $43.0 million in Q2 2024.
Net Income: Net income attributable to Ultralife was...